DermaSpark Wins 2nd Court Ruling on Counterfeit OxyGeneo

May 6, 2023
1–2 minutes

DermaSpark Products Inc., the exclusive distributor of the Health-Canada licensed OxyGeneo 3-in-1 super facial device, announced a second important victory against fake OxyGeneo devices, this time in the Quebec court system.  The honourable court rendered a  decision against a second counterfeit OxyGeneo machine user and seller. 

Read the full article here.

DermaSpark

Clinical Director, DermaSpark
Biomedical Engineer
Doron Heichal is Clinical Director at DermaSpark and a Biomedical Engineer specializing in evidence-based medical aesthetics, protocols, and clinical education to help Canadian clinics deliver safe, predictable patient outcomes.
View author profile on LinkedIn
Evaluating a Device for your clinic?
Speak with a DermaSpark specialist about equipment, treatment goals and business fit.
Contact us
Stay Informed
Clinical insights, new technologies and clinic growth ideas.
Receive selected DermaSpark articles and industry updates in your inbox.
Book a Demo